Ucitamet Tablet 50/1000 mg

Adult dose

The dosage of this medication is determined based on each patient's current treatment regimen, efficacy, and tolerance, without exceeding the recommended maximum daily doses of sitagliptin 100 mg and metformin 2000 mg. This medication is typically taken twice daily with meals, and the dosage is gradually increased to reduce gastrointestinal adverse effects from metformin. 1. Patients currently not treated with metformin:

This medication contains sitagliptin and metformin and is used for diabetes treatment. First, serious allergic reactions may occur while taking this medication, so if symptoms such as rash, hives, or shortness of breath develop, discontinue use immediately and consult a doctor. Additionally, acute pancreatitis, a serious inflammation of the pancreas, could occur. If symptoms such as abdominal pain, nausea, or vomiting appear, visit a hospital immediately. This medication should not be administered to patients with severely impaired kidney function or acute kidney failure; those with reduced kidney function should undergo regular kidney function tests. Patients with liver dysfunction or unstable health conditions such as severe infections, dehydration, or cardiovascular shock should also refrain from using this medication. It is not recommended for use in pregnant women, women who may become pregnant, or breastfeeding women. There is a risk of hypoglycemia with this medication, so caution is needed for patients with irregular eating habits, excessive exercise, or those taking other hypoglycemic agents. Mild side effects such as diarrhea, headache, and upper respiratory infections may occur during treatment, but these are typically not severe. Alcohol may increase the risk of side effects from this medication, so it should be avoided during use. Before undergoing surgery, this medication should be stopped at least 48 hours prior, and should only be restarted once kidney function is confirmed to be normal. During the course of treatment, blood sugar, kidney function, vitamin B12 levels, and other parameters should be regularly monitored to ensure there are no abnormalities. This medication has not been sufficiently proven safe and effective in children, so it is recommended against use in those under 18 years of age. Elderly patients may have an increased risk of decreased kidney function, so dosage adjustments and regular monitoring are necessary. In cases of overdose, immediate medical attention should be sought, as some components of this medication may be removed by hemodialysis. Finally, this medication may interact with other drugs, so any other medications being taken should be reported to a doctor or pharmacist.

Serious side effects

Hives, anaphylaxis, angioedema, Stevens-Johnson syndrome, severe swelling (edema), acute pancreatitis, acute kidney failure, respiratory distress, severe neurological symptoms (headaches, seizures, confusion, vision changes, paralysis), jaundice, thrombocytopenia, rhabdomyolysis, severe hypoglycemia, severe arthralgia, bullous pemphigoid, severe skin adverse reactions (severe rash, blisters, skin peeling, mucosal pain).

Mild side effects

• Diarrhea
• nausea
• vomiting
• abdominal pain
• upper respiratory infections
• nasopharyngitis
• headache
• weakness
• constipation
• myalgia

This medication should be stored in a sealed container to prevent air exposure and is best kept at room temperature between 1 and 30 degrees Celsius. Doing so helps maintain its effectiveness and prevents degradation.

Appearance

Dark red oval film-coated tablet

Package unit

56 tablets/box [(14 tablets/PTP x 4)], 30 tablets/bottle, 200 tablets/bottle